BrainLit develops patented lighting systems that bring daylight indoors, improving both health and performance. Our scientifically based, proven biocentric lighting helps support better sleep, a stronger immune system, and improved energy and focus.
In addition to natural day–night cycles, we offer lighting tailored to different activities – from ergonomic light for healthcare settings to “pre-game” and “post-game” lighting for sports teams. Biocentric lighting is widely used by teams in the Premier League, NFL, MLB, and NBA. Our portfolio also includes UVEN, a patented disinfection solution that neutralises infectious organisms in the air and on surfaces.
BrainLit’s first products were mainly sold to hotels, conference rooms, and offices. Over recent years, our solutions have been improved and simplified to be sold through distributors as plug-and-play products. At the same time, awareness of the importance of indoor lighting for health and performance has grown, and in early 2025 a new standard for healthy lighting was introduced, now reaching prescribers. By delivering biocentric lighting that meets and exceeds this standard, BrainLit is establishing itself as a leading provider of healthy lighting.
Our focus is now on the areas where the benefits are greatest. In sports and elite performance, we grew rapidly in the US during 2024, and since early 2025 we have seen strong demand from healthcare in Sweden and Denmark, particularly for operating theatres and intensive care units. The growth potential in healthcare is significant: in the US alone, the market for hospital and long-term care facility lighting is estimated to exceed SEK 10 billion annually. We see major opportunities to build and strengthen partnerships with specialised distributors worldwide.
A key part of our business model is ongoing knowledge-sharing with other stakeholders, such as manufacturers of light fittings and bulbs. Several have expressed interest in certifying their products in our lab and marketing them as biocentric under the “BCL Certified” label. This helps broaden the range of available products while also increasing demand for biocentric lighting. Our unique control box simplifies installation, operation, and maintenance, making it highly attractive to users, installers, and service teams.
2024 was marked by growth in the US, while sales in Sweden and the EU were affected by the construction sector downturn. However, we entered 2025 with a strong pipeline. Efficiency improvements reduced costs and operating losses. Early 2025 showed strong sales growth in both the EU and US, and by mid-year we had already surpassed 2024 revenue.
Our clear focus on healthcare in the EU has led to several groundbreaking deals, which we expect will strengthen opportunities to expand into larger markets through the establishment of specialised distributors.

